Grace Therapeutics
GRCE
#9749
Rank
HK$0.41 B
Marketcap
HK$27.00
Share price
4.20%
Change (1 day)
-16.71%
Change (1 year)

Revenue for Grace Therapeutics (GRCE)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Grace Therapeutics from 2010 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A-100%
2021 HK$0.89 M42.81%
2020 HK$0.62 M
2019 N/A
2018 N/A
2016 HK$0.08 M-90.72%
2015 HK$0.91 M-47.55%
2014 HK$1.75 M-24.2%
2013 HK$2.31 M-57.3%
2012 HK$5.41 M493.3%
2011 HK$0.91 M
2010 N/A